Cargando…

Recombinant human erythropoietin accelerated the proliferation of non‐small cell lung cancer cell lines and reduced the expression of VEGF, HIF‐1α, and PD‐L1 under a simulated hypoxic environment in vitro

BACKGROUND: As erythropoietin (EPO) has been used to treat anemia in cancer patients, negative controversy has continued. Unfortunately, its effects on non‐small‐cell lung carcinoma (NSCLC) cell lines are uncertain and the phenomenon of inducing immune escape of tumor cells remains to be explored. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yajing, Feng, Yangchun, Sun, Xiaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215718/
https://www.ncbi.nlm.nih.gov/pubmed/35774428
http://dx.doi.org/10.1002/cdt3.12